Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus sevoflurane for postoperative neurocognitive disorder in elderly elective surgery patients
ACTRN12626000486325Phase 4Not yet recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of remimazolam and sevoflurane in Postoperative neurocognitive disorder (PND) (2 arms), sponsored by University Hospital Center Sestre milosrdnice. Primary endpoint: Incidence of postoperative cognitive disorder. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
remimazolamsevoflurane
03
Conditions
Postoperative neurocognitive disorder (PND)
Beyond the preview
Go deeper on ACTRN12626000486325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000486325.